S. Menard et al., Pathobiologic identification of two distinct breast carcinoma subsets withdiverging clinical behaviors, BREAST CANC, 55(2), 1999, pp. 169-177
Many different pathological and biological variables which characterize bre
ast carcinomas have been found to be associated. The aim of this work was t
o analyze the complex relationship among these parameters. The pathologic,
biologic, and clinical characteristics of a series of primary breast carcin
omas from 676 patients were retrospectively investigated. Multiple correspo
ndence analysis of 13 factors revealed clustering of eight pathobiologic va
riables, that is histologic grade, necrosis, lymphoid infiltration, number
of mitoses, c-erbB-2 overexpression, p53, progesterone receptor, and bcl2 e
xpression. An index for each tumor calculated on the basis of these eight f
actors served to distinguish two different tumor phenotypes, designated A a
nd B. Phenotype A is represented by tumors sharing most of the biologic fea
tures of normal breast tissues: indeed, these tumors are characterized by a
relatively high degree of differentiation, low proliferation, no necrosis
or leukocyte infiltration, and no gene alterations. By contrast, phenotype
B is quite divergent from the normal tissue because of its poor differentia
tion, high proliferation, frequent gene alterations and evidence of a host
immune reaction. As regards the disease progression, these two subsets show
ed marked differences: phenotype A tumors had a low recurrence rate per yea
r that remained constant over time and affected more frequently elderly pat
ients, whereas group B tumors showed high aggressivity in the first years a
fter surgery followed by a low long-term recurrence rate and were more freq
uently seen in younger patients. These data suggest that breast carcinoma c
onsists of two different subsets that can be identified on the basis of pat
hobiologic features.